Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses.
Runhong ZhouKelvin Kai-Wang ToQiaoli PengJacky Man-Chun ChanHaode HuangDawei YangBosco Hoi-Shiu LamVivien Wai-Man ChuangJian-Piao CaiNa LiuKa-Kit AuOwen Tak-Yin TsangKwok-Yung YuenZhiwei ChenPublished in: Clinical and translational medicine (2022)